- 英文名称
- (6S,9R)-6-(2,3-Difluorophenyl)-9-((triisopropylsilyl)oxy)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-one
- 分子式
- C25H33F2NO2Si
- 分子量
- 445.62
- 中文别名
- (6S,9R)-6-(2,3-二氟苯基)-6,7,8,9-四氢-9-[[三(1-甲基乙基)甲硅烷基]氧基]-5H-环庚并[b]吡啶-5-酮; (6S,9R)-6-(2,3-二氟苯基)-6,7,8,9-四氢-9-[[三异丙基硅烷基]氧基]-5H-环庚三烯并[B]吡啶-5-酮; (6S,9R)-6-(2,3-二氟苯基)-6,7,8,9-四氢-9-[(三异丙基硅)氧基]-5H-环庚[B]吡啶-5-酮; BMS-846372杂质1; 瑞美吉泮中间体2; 瑞美吉泮杂质8; 瑞美吉泮中间体7; (6S,9R)-6-(2,3-Difluorophenyl)-6,7,8,9-tetrahydro-9-[[tris(1-methylethyl)silyl]oxy]-5H-cyclohepta[b]pyridin-5-one; (6S,9R)-6-(2,3-Difluorophenyl)-9-[(triisopropylsilyl)oxy]-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-one; (6S,9R)-6-(2,3-difluorophenyl)-9-(triisopropylsilyloxy)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-one; (6S,9R)-6-(2,3-difluorophenyl)-9-tri(propan-2-yl)silyloxy-6,7,8,9-tetrahydrocyclohepta[b]pyridin-5-one; BMS-846372 Impurity 1; Rimegepant Impurity 8; EOS-60325
- 用途
- 作为医药化学中间体用于药物分子瑞美吉泮的生产;其结构中硅基保护的活性羟基可在酸性条件下水解脱除保护基,羰基α碳原子手性中心对碱性物质敏感易发生烯醇式互变异构导致手性消失。